**Abstract**

**Objective:** Evidence in the extant literature has indicated associations between serotonin-related genetic variants and obsessive-compulsive disorder (OCD), but few studies have explored the involvement of serotonin receptor type 3 genes in OCD. The present study aimed to identify whether *HTR3* genetic variants may affect susceptibility to OCD.

**Methods:** Ten common *HTR3* variants were examined in 596 individuals with OCD and 599 controls. Single-marker association and haplotype-based association analyses were conducted regarding the affected status and different OCD sub-phenotypes, such as age at onset and clinical symptom dimensions. The impact of *HTR3* variants on trait disgust sensitivity was also analyzed.

**Results:** A significant difference in the genotype distribution of rs1176744 was detected between individuals with OCD and controls (odds ratio (OR) = 0.74, 95% confidence intervals (CI) = 0.60--0.91, *p* = 0.0044). A two-marker composite haplotype in *HTR3B* was also associated with OCD (OR = 0.77, CI = 0.63--0.95, permutated *p* = 0.0185). On analyzing clinical characteristics of OCD, significant associations were found for rs3758987 with age at onset in male subjects (OR = 0.49, CI = 0.30--0.78, *p* = 0.0025) and for rs6766410 and rs6443930 with the contamination/cleaning dimension in female subjects (OR = 0.36, CI = 0.18--0.69, *p* = 0.0017 and OR = 0.47, CI = 0.29--0.78, *p* = 0.0029, respectively). In addition, rs6766410 was significantly related to contamination-based disgust scores in the whole OCD sample (*p* = 0.0045).

**Conclusions:** Our results support a role for common variants of *HTR3* in OCD and certain of its clinical phenotypes. These findings may have implications for pharmacogenetic studies of 5-HT~3~ antagonists in the treatment of OCD.

Corresponding author: Se Joo Kim
